According to the SEC Form 4 filings, Leite John, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $1,246,533 | 5 | 100 |
| 2026-09-21 | Sale | Veracyte, Inc. VCYT | Global Chief Commercial Off | 4,015 0.0051% | $40.00 | $160,600 | +9.42% | |
| 2026-06-04 | Sale | Veracyte, Inc. VCYT | Global Chief Commercial Off | 13,975 0.018% | $50.07 | $699,732 | -7.35% | |
| 2026-03-04 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 5,260 0.0065% | $35.19 | $185,083 | +21.42% | |
| 2025-12-04 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 1,278 0.0016% | $47.51 | $60,718 | -9.47% | |
| 2025-11-25 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 2,808 0.004% | $50.00 | $140,400 | -12.74% | |
| 2025-10-01 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 2,539 0.0033% | $35.00 | $88,865 | +15.41% | |
| 2025-06-04 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 2,809 0.0036% | $27.20 | $76,410 | +26.82% | |
| 2025-03-07 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 7,411 0.0094% | $31.66 | $234,630 | +0.37% | |
| 2025-02-27 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 5,746 0.0074% | $33.84 | $194,445 | -5.02% | |
| 2024-12-03 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 1,050 0.0014% | $43.25 | $45,408 | -26.52% | |
| 2024-09-04 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 5,479 0.0072% | $29.78 | $163,159 | +8.19% | |
| 2024-07-16 | Sale | Veracyte, Inc. VCYT | Chief Commercial Officer-CLIA | 1,277 0.0019% | $25.00 | $31,925 | +26.37% |